Kanoria Chemicals Launches New 12 TPD Triacetin Facility in Ankleshwar
Kanoria Chemicals & Industries Limited launched a new 12 TPD Triacetin manufacturing facility in Ankleshwar, Gujarat. This expansion aims to bolster its specialty chemicals portfolio and serve growing domestic and international demand across food, pharma, and other industries.
The new facility expands the company's specialty chemicals portfolio and caters to growing market demand, which is expected to have a positive impact on revenue and market share.
The launch of a new manufacturing facility is a positive development for the company, indicating expansion and increased production capacity.
Kanoria Chemicals & Industries Limited (KCI) has announced the launch of a new 12 Metric Tons per Day (TPD) Triacetin manufacturing facility at its existing site in GIDC, Ankleshwar, Gujarat. The launch event was attended by Mr. Saumya Vardhan Kanoria, Whole Time Director, and Mr. Sanjay Ojha, Chief of Manufacturing & Projects - Chemical Business.
This new facility is designed to strengthen KCI's specialty chemicals portfolio and cater to the increasing demand for Triacetin in various sectors, including food and beverage, pharmaceuticals, agrochemicals, resins, coatings, and plastics, both in India and internationally. Mr. Sanjay Ojha stated that the facility enhances the company's capabilities in value-added products and will help meet growing customer requirements. He also expressed gratitude to the Government of Gujarat for their support.
KCI is a leading manufacturer of chemical intermediates in India, with diverse interests in chemicals, renewable energy, and textiles. The company operates three chemical manufacturing facilities and specializes in alcohol-based intermediates, phenolic resins, and specialty chemicals. KCI holds several key certifications, including ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, and RC14001:2015.
What to do with a filing like this
Kanoria Chemicals & Industries Limited filed this with the NSE as a statutory disclosure, categorised under product launches. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kanoria Chemicals & Industries Limited. Read the original for the full detail.